Rimonabant cas 168273-06-1 for Wight Loss   (jerryzhang001@chembj.com) - Nanjing Bangnuo Biotechnology Co., Ltd.

Rimonabant cas 168273-06-1 for Wight Loss   (jerryzhang001@chembj.com)

Product Description

Safe and Super Pure 99% Rimonabant CAS 168273-06-1 for Wight Loss


Rimonabant (also known as SR141716; trade names AcompliaZimulti) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects. It was approved for use in Europe and other countries, but never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It has also been shown to be a μ-opioid receptor antagonist (possibly the contributing factor in its reported dysphoric qualities).Its main effect is reduction in appetite.

Obesity Treatment

Rimonabant is a weight loss drug, can significantly reduce weight, reduce waist circumference and reduce risk factors for cardiovascular disease, but also can improve blood lipids and insulin resistance and metabolic syndrome, especially for the presence of clinical obesity or heart disease people at risk. 


Other products

Company Info

Nanjing Bangnuo Biotechnology Co., Ltd.
Contact Person:
Jerry Zhang